|
|
|||||||||||
David Meagher was the 1998 Eli-Lilly Royal College of Psychiatrists Travelling Fellow and spent a sabbatical studying the neuropsychiatry of delirium with Paula Trzepacz at the University of Mississippi. He is a consultant psychiatrist in the Midwestern Regional Hospital Limerick (Midwestern Regional Hospital Limerick, Department of Psychiatry, Limerick, Republic of Ireland; e-mail: davidjmeagher{at}ireland.com) and has ongoing interests in the study of phenomenology and management of delirious patients.
Acute mental disturbance associated with physical illness is well described in early medical literature, but it was not until 1 AD that Celsus coined the term delirium (Lindesay, 1999). Although delirium has many synonyms that are applied in particular clinical settings (Box 1
), all acute disturbances of global cognitive functioning are now recognised as delirium, a consensus supported by both ICD10 (World Health Organization, 1992) and DSMIV (American Psychiatric Association, 1994) classification systems. Delirium is a complex neuropsychiatric syndrome that typically involves a plethora of cognitive and non-cognitive symptoms, resulting in a broad differential diagnosis dominated by mental disorders. Psychiatrists' skills in assessing cognitive function and psychopathology, coupled with their knowledge of psychotropic agents, make them well suited to improving detection, coordinating management and facilitating research into this understudied disorder.
| Box 1 Delirium has many synonyms
|
| Symptoms of delirium |
|---|
|
|
|---|
|
|
| Frequency in clinical practice |
|---|
|
|
|---|
| Box 2 Prevalence of delirium in different populations
|
The presence of delirium is not always considered an indication for seeking psychiatric consultation (Francis et al, 1990). Nevertheless, delirium is common in patients referred to consultationliaison psychiatry services because it is frequently misdiagnosed by referring clinicians. Overall, approximately 10% of consultationliaiason referrals have delirium and around 10% of delirious general hospital patients receive a psychiatric consultation (Sirois, 1988; Francis et al, 1990), with the involvement of psychiatrists reserved for more complex cases. However, given the frequency of misdiagnosis and the tendency for treatment efforts to focus on underlying cause or behavioural problems rather than severity of actual delirium symptoms (Meagher et al, 1996), more frequent involvement of psychiatrists can improve management of delirium.
| Symptom overlap with other disorders |
|---|
|
|
|---|
The presentation of delirium can mimic functional psychiatric disorders. Emotional and behavioural changes of delirium are easily mistaken for adjustment reactions, particularly in patients who have experienced major trauma or have cancer. Delirium is frequently confused with depression, especially in females and those with hypoactive or lethargic delirium presentations (Nicholas & Lindsay, 1995; Armstrong et al, 1997). Most symptoms of major depression can occur in delirium (e.g. psychomotor slowing, sleep disturbances and irritability), but the onset of depressive illness is generally less acute and mood disturbance dominates the clinical picture. Moreover, cognitive impairment in depression typically resembles dementia more closely than delirium depressive pseudodementia. Hyperactive presentations of delirium can mimic similar disturbances in patients with anxiety disorders, agitated depression or mania. The overlap is further complicated by the fact that delirium can be precipitated by dehydration in patients with severe depression who cannot maintain fluid intake. However, accurate diagnosis of delirium is important because misdiagnosis as depression results in delayed treatment and exposure to antidepressant treatments, many of which have anticholinergic properties that can aggravate delirium.
The disturbances of thought and perception that occur in delirium are generally fluctuant and fragmentary and rarely have the complexity of psychotic symptoms that occur in schizophrenia. First-rank symptoms are uncommon and hallucinations tend to be visual rather than auditory. Consciousness, attention and memory are generally less impaired in schizophrenia, except in the acute phase of psychosis when marked perplexity can produce a pseudodelirious picture. Delirium involves both qualitative and quantitative alterations in consciousness, and in hypoactive patients can be associated with lethargy, but patients should be rousable. This differs from the marked reduction in consciousness with unrousability that occurs in comatose patients. In children, delirium can present with unexplained behavioural changes, the true nature of which only becomes apparent with close scrutiny of cognitive state.
| Underdiagnosis in clinical practice |
|---|
|
|
|---|
| Improving detection |
|---|
|
|
|---|
Psychiatrists can aid diagnosis by clarifying symptoms, assessing cognitive status and advising on supplementary investigation. Electroencephalography and a range of investigative tools that assess delirium symptoms (see below) can be useful in distinguishing delirium from dementia and functional psychiatric disorders. Delirium identification is improved when cognitive assessment is used routinely and can be enhanced by using simple screening instruments such as the Confusion Assessment Method (CAM; Inouye et al, 1990). Moreover, interventions aimed at increasing awareness of delirium and encouraging routine cognitive assessment with formal testing can increase detection of delirium and are reflected in improved outcomes (Rockwood, 1999).
| Psychiatrists' expertise in delirium management |
|---|
|
|
|---|
|
The pharmacological, environmental and psychological management of a delirium episode and its aftermath has been reviewed in detail elsewhere (American Psychiatric Association, 1999; Meagher, 2001). The principles of good ward management of delirious patients include ensuring the safety of the patient and their immediate surroundings, achieving optimal levels of environmental stimulation and minimising the effects of any sensory impediments. Reorientation is facilitated by a predictable environment with clear communication from carers and provision of multiple cues and frequent reminders as to circumstances and setting. The complications of delirium can be minimised by careful attention to the potential for falls and avoiding prolonged hypostasis. Psychiatrists can advise regarding the appropriateness and dosing of drug treatment and help monitor treatment response. Medication use in delirium often represents a response to problem behaviours rather than the severity of actual delirium symptoms. No placebo-controlled trials of pharmacological treatments for delirium have been conducted, but typical antipsychotics, especially haloperidol, are widely used. The available evidence suggests that antipsychotics are effective in alleviating a range of delirium symptoms in patients with either hyperactive or hypoactive clinical profiles (Platt et al, 1994). Moreover, their therapeutic impact is not merely due to their sedative effects and may reflect a specific antidelirium effect, perhaps mediated by effects on the dopamineacetylcholine balance. Appropriate doses for delirium treatment have not been established, but low-dose haloperidol is appropriate for most patients who require drug treatment. However, caution is required when delirium symptoms occur in the setting of suspected Lewy body dementia, as serious adverse effects can occur with antipsychotic use, and preliminary evidence suggests that alternative strategies such as procholinergic agents may be more appropriate in these cases. A range of other psychotropic agents have been suggested as therapeutic options (e.g. mianserin, trazodone and atypical antipsychotics), but their role and relationship to more standard drug treatments remains to be determined. Benzodiazepine use in delirium requires careful consideration as they are less effective than antipsychotics except in substance/alcohol-related deliria and have the disadvantage of operating as potential aggravating factors in delirium (Breitbart et al, 1996). However, benzodiazepines can be a useful adjunctive treatment in patients prone to adverse effects from antipsychotic agents.
Psychiatrists have the necessary skills to provide supportive psychotherapeutic input and interaction with relatives and carers that is fundamental to good management of delirium. Relatives can play an integral role in efforts to support and reorientate delirous patients, but ill-informed, critical or anxious carers can add to the burden of a delirious patient. A therapeutic triangle can emerge whereby medical staff respond to the distress of relatives by medicating patients, which in turn complicates ongoing cognitive assessment. Clarification of the cause and meaning of symptoms combined with recognition of treatment goals can allow better management of what is a distressing experience for both patient and loved ones.
The after-care of delirium has received limited study, but denial, depression and post-traumatic stress disorder are recognised psychological sequelae. Recovered patients are often uncom-fortable discussing the experience, but most do recognise its transient nature (Schofield, 1997). Simple clarification can reduce the likelihood of patients or their relatives misinterpreting an episode of delirium as evidence of brain damage or as the first step towards senility or madness. Patient's unwillingness to acknowledge the experience may negatively influence their attitude to help-seeking for medical problems in the future. Inouye et al (1999) have demonstrated the positive impact of a risk factor reduction programme on reducing the number and duration of delirium episodes in hospitalised elderly patients. Explicit recognition of delirium and its associated causes allows minimisation of future exposure to risk factors.
| Delirium management: a challenge for psychiatry services |
|---|
|
|
|---|
Involvement of psychiatry services tends to occur late in treatment efforts and frequently reflects a desire for advice on placement issues rather than acute treatment. Earlier intervention has many advocates and can positively influence outcome. Referral practices are biased towards hyperactive and disturbed patients, but there is a need for greater emphasis of the less obvious somnolent or hypoactive clinical subtype (Meagher & Trzepacz, 2000). Although hypoactive patients are perceived as less morbid, they have poorer outcomes that, in part, reflect poorer identification and less aggressive treatment. Moreover, the efficacy of antipsychotics in the treatment of patients with both hypoactive and hyperactive profiles is poorly appreciated (Platt et al, 1994), with much lower utilisation of antipsychotic agents in hypoactive patients (Meagher et al, 1996). Psychiatry services therefore need to be more proactive in identifying hypoactive patients.
Modern consultationliaiason psychiatry services are often overburdened with the demands posed by functional psychiatric disorders and deliberate self-harm. Although it is difficult to provide delirium assessment in such services, the potential benefits are compelling. Psychiatrists can make valuable contributions at many points along the care pathway for patients with delirium (Fig. 2
) and their involvement is associated with clinical improvement in delirium (Hales et al, 1988). In addition, immense financial savings can accrue from reduction of in-patient stays by a single day a goal that is attainable with systematic treatment interventions (Cole et al, 1994). The shift of in-patient psychiatric care to general hospital settings has made it more feasible for psychiatrists to contribute to the management of delirium and the potential benefits suggest that delirium warrants higher priority as services evolve.
| Formal assessment of delirium |
|---|
|
|
|---|
Numerous screening instruments for impaired cognition are available, but a reliable distinction between delirium and dementia requires that the mode of onset and course of symptoms are accounted for. Formal delirium diagnosis requires documentation of acute onset and fluctuant course. As a result, cognitive impairment identified with instruments such as the Mini-Mental State Examination (MMSE; Folstein et al, 1975) must be supplemented by application of DSM or ICD criteria, either by an experienced clinician or with an operationalised instrument (Table 2
). The CAM is an operationalisation of key components of DSMIIIR that has high sensitivity and specificity, allows a diagnosis of delirium and is readily incorporated as a screen for delirium into routine clinical settings. However, it has reduced sensitivity when used by nursing staff rather than physicians (see Box 3
).
|
| Box 3 Confusion Assessment Method (CAM) Delirium diagnosed if (a) + (b) + one of either (c) or (d):
|
The important attributes of scales for assessing delirium symptom severity are outlined in Table 2
. These instruments generally have good coverage of delirium symptoms and are suitable for serial use. The Delirium Rating Scale (DRS; Trzepacz et al, 1998) is the most widely used to date and, although it requires interpretation by a skilled clinician of information from multiple clinical sources, it has the significant advantage of distinguishing between the disturbances of delirium and dementia. Scores have been shown to predict duration of delirium episode, correlate with frequency of complications and reflect improving clinical state linked to successful drug treatment (Rutherford et al, 1991; Wada & Yamaguchi, 1993; Nakamura et al, 1997). The revised version (DRS98; Trzepacz et al, 2000) incorporates more detailed cognitive assessment (including specific items for disturbances of attention, thought processes and language function) and has separate items for both reduced and increased motor activity. Psychometric evaluation is ongoing (Trzepacz et al, 2000).
Many patients with delirium are physically very unwell and their ability to cooperate with detailed assessments of multiple neuropsychological functions is limited. As a consequence, the instruments that have been applied to delirium research have not involved detailed investigation of the range and complexity of neuropsychological disturbances that can occur. The MMSE has been used in many studies but does not distinguish between acute and chronic disturbances, is heavily reliant on subject cooperation (e.g. verbal capacity) and emphasises neuropsychological functions linked to left-cerebral hemispheric activity. Trail-making tests are superior to the MMSE in distinguishing delirium from dementia (Trzepacz et al, 1988b) but lack specificity, and performance is significantly reduced by any condition that affects concentration, motivation or is associated with fatigue. Consequently, they have limited applicability to highly morbid populations with delirium. More recently, it has become increasingly apparent that many of the core disturbances of delirium reflect non-dominant hemispheric functions. Attention, for example, is related to non-dominant orbitofrontal, prefrontal and posterior parietal regions. Moreover, recent work suggests that right-sided cognitive functions are especially helpful in distinguishing delirium from dementia and functional psychotic disorders (Hart et al, 1997). The Cognitive Test for Delirium (CTD; Hart et al, 1996) is a recently developed instrument that allows detailed investigation of a range of neuropsychological functions (orientation, comprehension, attention, vigilance and memory) and is suitable for use in patients whose ability to interact with the examiner may be compromised by immobility, intubation or an absence of verbal abilities. This instrument is therefore a significant advance that should allow greater characterisation of the neuropsychological impairments of delirium, their relationship to non-cognitive symptoms and a range of other important aspects of clinical profile such as underlying aetiology, treatment responsiveness and course.
| Contribution of consultationliaison psychiatry to delirium research |
|---|
|
|
|---|
| Conclusions |
|---|
|
|
|---|
| Multiple choice questions |
|---|
|
|
|---|
|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSMIV). Washington DC: APA.
* (1999) Practice Guidelines for the Treatment of Patients with Delirium. Washington, DC: APA.
Armstrong, S. C., Cozza, K. L. & Watanabe, K. S. (1997) The misdiagnosis of delirium. Psychosomatics, 38, 433439.
Breitbart, W., Marotta, R., Platt, M. M., et al (1996) A double blind trial of haloperidol, chlorpromazine and lorazepam in the treatment of delirium in hospitalised AIDS patients. American Journal of Psychiatry, 153, 231237.
Bucht, G., Gustafson, Y. & Sandberg, O. (1999). Epidemiology of delirium. Dementia and Geriatric Cognitive Disorders, 10, 315318.[CrossRef][Medline]
Cole, M. G., Primeau, F. J., Bailey, R. F., et al (1994) Systematic intervention for elderly in-patients with delirium: a randomised trial. Canadian Medical Association Journal, 151, 965970.[Abstract]
Fann, J. R. (2000) The epidemiology of delirium: a review of studies and methodological issues. Seminars in Clinical Neuropsychiatry, 5, 6476.[Medline]
Folstein, M. F., Folstein, S. E., McHugh, P. R. (1975) Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 18998.[CrossRef][Medline]
Francis, J., Martin, D. & Kapoor, W. N. (1990) A prospective study of delirium in hospitalised elderly. Journal of the American Medical Association, 263, 10971101.[Abstract]
Hales, R. E., Polly, S. & Orman, D. (1988) An evaluation of patients who received an organic mental disorder diagnosis on a psychiatric consultation-liaison service. General Hospital Psychiatry, 11, 8894.
*, R. P., Levenson, J. L., Sessler, C. N., et al (1996) Validation of a cognitive test for delirium in medical ICU patients. Psychosomatics, 37, 533546.
*, R. P., Best, A. M., Sessler, C. N., et al (1997) Abbreviated Cognitive Test for delirium. Journal of Psychosomatic Research, 43, 417423.[CrossRef][Medline]
Inouye, S. K., van Dyck, C. H., Alessi, C. A., et al (1990) Clarifying confusion: the Confusion Assessment Method: a new method for detection of delirium. Annals Internal Medicine, 113, 941948.
*, Bogardus, S. T., Charpentier, P. A., et al (1999) A multicomponent intervention to prevent delirium in hospitalized older patients. New England Journal of Medicine, 340, 669676.
Johnson, J. C., Curse, N. M., Gottlieb, G., et al (1992) Prospective versus retrospective methods of identifying patients with delirium. Journal of the American Geriatric Society, 40, 316319.
Lewis, L. M., Miller, D. K., Morley, J. E., et al (1995) Unrecognized delirium in emergency department geriatric patients. American Journal Emergency Medicine, 13, 142145.
Lindesay, J. (1999) The concept of delirium. Dementia and Geriatric Cognitive Disorders, 10, 310315.[CrossRef][Medline]
*Meagher, D. J. (2001). Delirium: optimising management. BMJ, 322, 144149.
* Trzepacz, P. T. (2000) Motoric subtypes of delirium. Seminars in Clinical Neuropsychiatry, 5, 7686.
*, O'Hanlon, D., O'Mahony, E., et al (1996) Use of environmental strategies and psychotropic medication in the management of delirium. British Journal of Psychiatry, 168, 512515.
Nakamura, J., Uchimura, S., Yamada, S., et al (1997) Does plasma free-3-methoxy-4-hydroxyphenyl(ethylene)glycol increase in the delirious state? A comparison of the effects of mianserin and haloperidol on delirium. International Clinical Psychopharmacology, 12, 147152.[Medline]
Nicholas, L. M. & Lindsay, B. A. (1995) Delirium presenting with symptoms of depression. Psychosomatics, 36, 471479.
O'Keeffe, S. T. (1994) Rating the severity of delirium: the Delirium Assessment Scale. International Journal of Geriatric Psychiatry, 9, 551556.[CrossRef]
& Gosney, M. (1997) Assessing attentiveness in older hospital patients: global assessment versus tests of attention. Journal of the American Geriatrics Society, 45, 470473.[Medline]
Platt, M. M., Breitbart, W., Smith, M., et al (1994) Efficacy of neuroleptics for hypoactive delirium. Journal of Neuropsychiatry and Clinical Neurosciences, 6, 6667.
Robertsson, B. (1999) Assessment scales in delirium. Dementia and Geriatric Cognitive Disorders, 10, 368379.[CrossRef][Medline]
*Rockwood, K. (1999). Educational interventions in delirium. Dementia and Geriatric Cognitive Disorders, 10, 426429.[CrossRef][Medline]
*, Cosway, S., Stolee, P., et al (1994) Increasing the recognition of delirium in elderly patients. Journal of the American Geriatrics Society, 42, 252256.[Medline]
Rutherford, L. E., Sessler, C. N., Levenson, J. L., et al (1991) Prospective evaluation of delirium and agitation in a medical intensive care unit. Critical Care Medicine, 19, S81.
Schofield, I. (1997) A small exploratory study of the reaction of older people to an episode of delirium. Journal of Advanced Nursing, 25, 942952.[CrossRef][Medline]
Sirois, F. (1988) Delirium: 100 cases. Canadian Journal of Psychiatry, 33, 375378.[Medline]
Trzepacz, P. T., Brenner, R., Coffman, G., et al (1988a) Delirium in liver transplant candidates: discriminant analysis of multiple test variables. Biological Psychiatry, 24, 314.[CrossRef][Medline]
Trzepacz, P. T., Baker, R. W., Greenhouse, J. (1988b) A symptom rating scale for delirium. Psychiatry Research, 23, 8997.[CrossRef][Medline]
Trzepacz, P. T., Mulsant, B. H., Dew, M. A., et al (1998) Is delirium different when it occurs in dementia? A study using the delirium rating scale. Journal of Neuropsychiatry and Clinical Neurosciences, 10, 199204.
Trzepacz, P. T., Mittal, D., Torres, R., et al (2000) Validation of the Delirium Rating ScaleRevised98 (DRSR98). Journal of Neuropsychiatry and Clinical Neurosciences, 12, 156.
Wada, Y. & Yamaguchi, N. (1993) Delirium in the elderly: relationship of clinical symptoms to outcome. Dementia, 4, 113116.
Wahlund, L. A. & Bjorlin, G. A. (1999) Delirium in clinical practice: experiences from a specialized delirium ward. Dementia and Geriatric Cognitive Disorders, 10, 389392.[CrossRef][Medline]
World Health Organization (1992) The ICD10 Classification of Mental and Behavioural Disorders. Geneva: WHO.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| British Journal of Psychiatry | Psychiatric Bulletin | All RCPsych Journals |